The Next Horizon of Innovation for Pharma

The Pharma Dispatch is a hand-curated newsletter compiled weekly to go beyond the headlines and bring you the most interesting developments related to the pharmaceutical, biotech and medical research from around the world.

An executive partner at Flagship Pioneering discusses what’s next for the industry, disruptive technologies, and patient care.

Can billions of dollars’ worth of high-tech research succeed in making death optional?

A drug derived from an Easter Island bacterium extends the life of lab animals. People could be next.

CARB-X awards up to $48 million to 11 companies to jump-start development of antibiotics and nontraditional approaches to target superbugs.

Pharma would seemingly best biotech in any competition. A few CEO's explain why it left the honor of “The World’s First Gene Therapy” to biotech.

Examine the current and future trends for life sciences and healthcare M&A

Thank You!

If you made it this far, thanks for reading. I’d love to hear which specific topics or sections you would like to know more about and in general, if you have any suggestions, please do write to me at: [email protected]